BR9810331A - Sal de adição de ácido maléico de 2-etil-5-(1-metil-1,2,5,6-tetraidro-3-piridil-2h-tetrazol ; composições farmacêuticas contendo o referido sal; método para sua preparação e a utilização do mesmo em tratamento de doenças - Google Patents
Sal de adição de ácido maléico de 2-etil-5-(1-metil-1,2,5,6-tetraidro-3-piridil-2h-tetrazol ; composições farmacêuticas contendo o referido sal; método para sua preparação e a utilização do mesmo em tratamento de doençasInfo
- Publication number
- BR9810331A BR9810331A BR9810331-8A BR9810331A BR9810331A BR 9810331 A BR9810331 A BR 9810331A BR 9810331 A BR9810331 A BR 9810331A BR 9810331 A BR9810331 A BR 9810331A
- Authority
- BR
- Brazil
- Prior art keywords
- salt
- ethyl
- methyl
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK78197 | 1997-07-01 | ||
| PCT/DK1998/000294 WO1999001448A1 (en) | 1997-07-01 | 1998-07-01 | 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9810331A true BR9810331A (pt) | 2000-09-05 |
Family
ID=8097489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9810331-8A BR9810331A (pt) | 1997-07-01 | 1998-07-01 | Sal de adição de ácido maléico de 2-etil-5-(1-metil-1,2,5,6-tetraidro-3-piridil-2h-tetrazol ; composições farmacêuticas contendo o referido sal; método para sua preparação e a utilização do mesmo em tratamento de doenças |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0994869A1 (ko) |
| JP (1) | JP2002507215A (ko) |
| KR (1) | KR20010014297A (ko) |
| CN (1) | CN1261361A (ko) |
| AR (1) | AR013096A1 (ko) |
| AU (1) | AU735751B2 (ko) |
| BG (1) | BG103933A (ko) |
| BR (1) | BR9810331A (ko) |
| CA (1) | CA2293324A1 (ko) |
| CO (1) | CO4940483A1 (ko) |
| EA (1) | EA200000081A1 (ko) |
| HU (1) | HUP0002876A2 (ko) |
| IL (1) | IL133093A0 (ko) |
| IS (1) | IS5278A (ko) |
| JO (1) | JO2031B1 (ko) |
| MA (1) | MA25138A1 (ko) |
| NO (1) | NO996580L (ko) |
| PE (1) | PE116099A1 (ko) |
| PL (1) | PL337184A1 (ko) |
| SK (1) | SK187399A3 (ko) |
| TN (1) | TNSN98120A1 (ko) |
| TR (1) | TR199903283T2 (ko) |
| UY (2) | UY25069A1 (ko) |
| WO (1) | WO1999001448A1 (ko) |
| ZA (1) | ZA985498B (ko) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| TR199800801T2 (xx) * | 1995-11-06 | 1998-08-21 | H. Lund-Beck A/S | Travmatik beyin yaralanmalar�n�n tedavisi. |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/es not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/xx unknown
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-25 PE PE1998000563A patent/PE116099A1/es not_active Application Discontinuation
- 1998-06-26 CO CO98036576A patent/CO4940483A1/es unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/es not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/fr unknown
- 1998-07-01 EP EP98930655A patent/EP0994869A1/en not_active Withdrawn
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/pt not_active Application Discontinuation
- 1998-07-01 CA CA002293324A patent/CA2293324A1/en not_active Abandoned
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/xx unknown
- 1998-07-01 JP JP50616699A patent/JP2002507215A/ja active Pending
- 1998-07-01 MA MA25155A patent/MA25138A1/fr unknown
- 1998-07-01 EA EA200000081A patent/EA200000081A1/ru unknown
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 CN CN98806497A patent/CN1261361A/zh active Pending
- 1998-07-01 SK SK1873-99A patent/SK187399A3/sk unknown
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/hu unknown
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/ko not_active Application Discontinuation
- 1998-07-01 PL PL98337184A patent/PL337184A1/xx unknown
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/en not_active Application Discontinuation
- 1998-07-01 IL IL13309398A patent/IL133093A0/xx unknown
- 1998-09-10 UY UY25177A patent/UY25177A1/es not_active Application Discontinuation
-
1999
- 1999-11-30 IS IS5278A patent/IS5278A/is unknown
- 1999-11-30 BG BG103933A patent/BG103933A/xx unknown
- 1999-12-30 NO NO996580A patent/NO996580L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE116099A1 (es) | 1999-11-23 |
| JP2002507215A (ja) | 2002-03-05 |
| CO4940483A1 (es) | 2000-07-24 |
| BG103933A (en) | 2000-07-31 |
| CA2293324A1 (en) | 1999-01-14 |
| IS5278A (is) | 1999-11-30 |
| AR013096A1 (es) | 2000-12-13 |
| SK187399A3 (en) | 2000-06-12 |
| NO996580D0 (no) | 1999-12-30 |
| HUP0002876A2 (hu) | 2001-06-28 |
| CN1261361A (zh) | 2000-07-26 |
| TR199903283T2 (xx) | 2000-06-21 |
| AU735751B2 (en) | 2001-07-12 |
| AU8102098A (en) | 1999-01-25 |
| NO996580L (no) | 1999-12-30 |
| JO2031B1 (en) | 1999-05-15 |
| MA25138A1 (fr) | 2001-04-02 |
| PL337184A1 (en) | 2000-08-14 |
| EP0994869A1 (en) | 2000-04-26 |
| UY25069A1 (es) | 1998-12-21 |
| WO1999001448A1 (en) | 1999-01-14 |
| UY25177A1 (es) | 2000-12-29 |
| EA200000081A1 (ru) | 2000-08-28 |
| ZA985498B (en) | 1999-01-20 |
| IL133093A0 (en) | 2001-03-19 |
| KR20010014297A (ko) | 2001-02-26 |
| TNSN98120A1 (fr) | 2005-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69017302D1 (de) | Zentrale Cholecystokinin-Antagonisten zur Behandlung von psychiatrischen Krankheiten. | |
| IL152659A (en) | Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer | |
| BRPI0108977B8 (pt) | compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo | |
| BR0309875A (pt) | métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto | |
| WO2002042462A3 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| MA26420A1 (fr) | Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation. | |
| ATE398618T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von zns und anderen krankheiten | |
| BR0110487A (pt) | Composição farmacêutica e método de tratamento de doenças de disfunção cognitiva em um mamìfero | |
| BR0015506A (pt) | Conjugados de interferon gama, métodos para sua preparação, composições farmacêuticas que compreendem ás moléculas e seu uso no tratamento de doenças | |
| BG101118A (en) | Therapeutical compounds | |
| ATE348829T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von störungen des zns oder anderen erkrankungen | |
| MA26471A1 (fr) | Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| WO2003048164A3 (en) | Adenosine a2a receptor antagonists | |
| GEP20033081B (en) | Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas | |
| CA2378613A1 (en) | Selective iglur5 receptor antagonists for the treatment of migraine | |
| BR9909958A (pt) | Formulação farmacêutica, respectivos processo de preparação e uso e método de tratamento ou prevenção de distúrbios ósseos | |
| BR9611124A (pt) | Utilização da 1-(2-naft-2-iletil)-4- (3-trifluorometifenil) -1,2,3,6-tetraidropiridina ou um dos seus sais de adição com ácidos farmaceuticamente aceitáveis composição farmacéutica e método de tratamento da esclerose lateral amiotrófica | |
| CA2132544A1 (en) | Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy | |
| BR9810331A (pt) | Sal de adição de ácido maléico de 2-etil-5-(1-metil-1,2,5,6-tetraidro-3-piridil-2h-tetrazol ; composições farmacêuticas contendo o referido sal; método para sua preparação e a utilização do mesmo em tratamento de doenças | |
| ATE187956T1 (de) | Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel | |
| BR9913348A (pt) | Tratamento dos distúrbios da ansiedade | |
| PT1231908E (pt) | Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia | |
| BR0005319A (pt) | Tratamento combinado para depressão e ansiedade | |
| WO1999021005A3 (en) | Pharmaceutical grade st. john's wort | |
| BR9808428A (pt) | Composição farmacêutica, processo para tratar distúrbios alérgicos em um mamìfero e forma de dosagem unitária sólida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |